Breast Cancer More Deadly In Young Black Women

Young black women with breast cancer are more likely to develop a particularly deadly and hard to treat tumor type than either whites or older blacks, according to a study published this week in the Journal of the American Medical Association. The reason perplexes researchers but a genetic component is suspected. Basal-like tumors are the most common kind found in Africa, according to Dr. Larry Norton, a breast cancer expert at Memorial Sloan-Kettering Cancer Center in New York.

"Among premenopausal black women with breast cancer, 39% had the more dangerous kind, called a 'basal-like' subtype, compared with only 14% of older black women and 16% of non-black women of any age," writes Denise Grady in The New York Times. (Click our post title to read the entire article.)

While chemotherapy can help, basal-like tumors are more likely to be fatal because they do not respond to tamoxifen, raloxifene or herceptin, the standard drugs used to fight breast cancer. As I detail in my video, Cancer Conquest, the battle must be fought on multiple fronts. Alternative medical treatments can enhance traditional medical protocols, the combination often succeeding where drug therapy alone fails.

By using pharmogenomics, an exciting cutting-edge cancer treatment, personal genetics are used to determine individual treatment regimens. Visit http://www.burtongoldberg.com/promo.html for more information on my video, pharmogenomics, and other new alternative and integrative cancer therapies.